Observational studyRheumatology international2022

Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis.

Delamo I Bekele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.